pharma
Novartis’s Tasigna scores EU approval in paediatric patients
November 20, 2017Sales and Marketing Europe, Novartis, Tasigna, chronic myeloid leukaemia, pharma
Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …
UK austerity measures to social care led to 120,000 deaths
November 17, 2017Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care
A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …
FDA expands use of Pfizer’s Sutent in kidney cancer
November 17, 2017Medical Communications, Sales and Marketing Cancer, Kidney cancer, Pfizer, Sutent, pharma
Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …
Roche’s haemophillia A treatment gets nod but with black box warning
November 17, 2017Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …
Boots under fire from Labour MPs over broken contraceptive promise
November 17, 2017Medical Communications, Sales and Marketing Boots, biotech, drugs, morning after pill, pharma, pharmaceutical
Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …
Stem cell therapy fails to improve symptoms of peripheral artery disease
November 16, 2017Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure
A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …
FDA approves electronic nerve stimulator for opioid withdrawal
November 16, 2017Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …
GSK gets EU go-ahead for triple therapy inhaler in COPD
November 16, 2017Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma
The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …
NICE approves Novartis and Pfizer’s rival breast cancer drugs
November 16, 2017Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical
NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …
Genentech cements relationship with Arvinas with $650m deal
November 16, 2017Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
Navigating the new Clinical Trial Regulation with DIA
November 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical
For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
NHS backs innovative means of cutting diabetes risk
November 15, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …
Promising new CAR-T therapy able to target T-cell lymphoma
November 15, 2017Research and Development Autolus, CAR T, CAR-T, biotech, drugs, pharma, pharmaceutical
The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …
Psoriasis patients at greater risk of type 2 diabetes, study reveals
November 15, 2017Research and Development diabetes, pharma, psoriasis, type 2 diabetes
Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …
FDA signals crackdown on controversial painkiller
November 15, 2017Medical Communications, Research and Development biotech, drugs, kratom, pharma, pharmaceutical
Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
